Unlike Starlink, which is fully owned and operated by SpaceX, IRIS² is being built through a public-private partnership. The ...

The Trump administration may stop all shipments of military aid to Ukraine following a tense exchange between President ...

Many of the top-performing stocks and assets in recent years have stumbled at the start of 2025, with Bitcoin (CRYPTO: BTC) ...

Fluor FLR has outperformed the market over the past 5 years by 17.19% on an annualized basis producing an average annual ...

With a volume of 1,713,422, the price of RCL is up 2.41% at $243.89. RSI indicators hint that the underlying stock is ...

The general mood among these heavyweight investors is divided, with 44% leaning bullish and 38% bearish. Among these notable ...

Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...

2 market experts have recently issued ratings for this stock, with a consensus target price of $130.5.

Piper Sandler analyst Yasmeen Rahimi initiated coverage on Avalo Therapeutics, Inc. AVTX with an Overweight rating and ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

WestPark Capital analyst reaffirms Buy rating on Okta with $140 price target. Q4 and FY25 results to be reported on March 3.

From Walgreens' breakup to Forever 21's pending bankruptcy, M&A and drama unfold in this week's edition of Deal Dispatch.